Recipharm Site in France Approved for Supply to Japan
News Apr 02, 2013
The product dossier was presented by one of Recipharm’s contract manufacturing customers, which also secured regulatory approval for its supply to Japan.
The Fontaine plant, which employs 190 people, is one of Recipharm’s solid dose forms facilities and until 2009 was owned by Solvay Pharma (now Abbott). The facility is also approved to supply to the US.
In addition to manufacturing, the site has a logistics and packaging centre.
Recipharm now supplies products to the Japanese, US, and European markets from a number of European facilities.
The Stockholm, Sweden-based firm says the development marks a significant step forward in its international expansion.
Stéphane Guisado, Recipharm Fontaine´s General Manager, said: ‘As a result of this approval, we are now in a good position to further support other customers with their plans to penetrate and expand sales in specific pharmaceutical markets within Japan.’
Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS VaccineNews
The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018